Internal Medicine, Rheumatology · Ithaca, NY
NPI
1891725396
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
1301 Trumansburg Road, Suite R
Ithaca, NY, 14850
Phone (607) 277-2710
Groups this clinician bills Medicare through
Medicare paid, 2024
$82K
1,180 services
Medicare patients, 2024
383
Average age 71
Drug cost, 2024
$5.5M
4,085 prescriptions
Company payments, 2025
$2,344
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Robert J Meador Jr. was code 99214 (office e&m - established), 782 times for 327 patients. In total Robert J Meador Jr. billed 1,180 services in 21 codes, and Medicare paid $82K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-10-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 782 | 327 | $83.84 | $66K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 104 | 14 | $0.63 | $65.14 |
| 99204 Office E&M - New | Office | 67 | 67 | $114.69 | $7,684 |
| 99213 Office E&M - Established | Office | 58 | 51 | $66.19 | $3,839 |
| 96372 Injection Administration | Office | 32 | 17 | $9.11 | $291 |
By year: 2022 $82K for 1,283 services; 2023 $82K for 1,219 services; 2024 $82K for 1,180 services.
Medicare prescription drug claims, 2024
In 2024, the drug Robert J Meador Jr. prescribed most often to Medicare patients was Prednisone, with 545 prescriptions and refills. In total Robert J Meador Jr. wrote 4,085 Medicare prescriptions that cost $5.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 545 | 1,101 | 152 | $5,648 |
| Hydroxychloroquine Sulfate Generic | 465 | 1,055 | 135 | $17K |
| Methotrexate Methotrexate Sodium | 436 | 1,069 | 134 | $12K |
| Sulfasalazine Generic | 168 | 305 | 49 | $3,463 |
| Gabapentin Generic | 167 | 294 | 47 | $1,764 |
| Duloxetine Hcl Generic | 103 | 224 | 28 | $3,424 |
| Enbrel Mini Etanercept | 94 | 107 | 12 | $769K |
| Tizanidine Hcl Generic | 88 | 105 | 23 | $1,499 |
| Celecoxib Generic | 75 | 117 | 28 | $4,141 |
| Allopurinol Generic | 74 | 198 | 19 | $911 |
| Humira(Cf) Pen Adalimumab | 72 | 117 | 14 | $781K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 67 | 67 | 13 | $929 |
| Alendronate Sodium Generic | 61 | 137 | 17 | $514 |
| Pregabalin Generic | 57 | 57 | 12 | $2,131 |
| Actemra Tocilizumab | 50 | 50 | Under 11 | $167K |
Brand drugs: - claims; generic drugs: 3,151 claims; opioid claims: 180.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Robert J Meador Jr. $2,344 ($2,344 in general payments such as food, travel and fees) from 19 companies. The largest payer was Amgen Inc. with $357.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 20 | $357 |
| Abbvie Inc. ABBV | 18 | $330 |
| UCB, Inc. UCB.BR | 13 | $287 |
| ANI Pharmaceuticals, Inc. ANIP | 15 | $236 |
| AstraZeneca Pharmaceuticals LP AZN | 11 | $212 |
| Novartis Pharmaceuticals Corporation NVS | 12 | $194 |
| Janssen Biotech, Inc. JNJ | 7 | $140 |
| GlaxoSmithKline, LLC. GSK | 5 | $117 |
| Pfizer Inc. PFE | 5 | $93.54 |
| Mallinckrodt Hospital Products Inc. | 5 | $91.4 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.